Question

Phase I of FDA testing involves human testing for efficacy of Drug (IND). Investigational New an True False
0 0
Add a comment Improve this question Transcribed image text
Answer #1

False

In phase one of FDA testing involves human testing for dosage and safety  of an IND in <30healthy volunteers/ Patients.

In phase 2 more patients would be involved usually 100 or <100 with the disease/condition..Efficacy and sideeffects are studied in this phase.

In phase 3, 300 to 3,000 volunteers who have the disease or condition.Efficacy and monitoring of adverse reactions will be done .

In phase 4 Several thousand volunteers who have the disease/condition are participated in the study, and safety and efficacy of the drung will be studied

Add a comment
Know the answer?
Add Answer to:
Phase I of FDA testing involves human testing for efficacy of Drug (IND). Investigational New an...
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for? Ask your own homework help question. Our experts will answer your question WITHIN MINUTES for Free.
Similar Homework Help Questions
  • Which of the following correctly orders the drug approval process? IND Application, Animal Testing, Phase 1...

    Which of the following correctly orders the drug approval process? IND Application, Animal Testing, Phase 1 NDA Application, Phase 2, Facility Inspection Animal Testing, IND Application, Phase 1 Animal Testing, Phase 1, IND Application With this type of research those who must evaluate the results of a treatment are kept ignorant of which patients have received it. Double-blind study Randomized clinical trial Crossover study Single-blind study The video from the University of Wisconsin Madison involved A dog named Oreo A...

  • The FDA commits a Type I error when it: A. allows a harmful drug onto the...

    The FDA commits a Type I error when it: A. allows a harmful drug onto the market before it has been fully tested. B. receives fees for testing a new drug. C. delays a safe drug from going to market which reduces competition and raises costs. D. decides to pull a safe drug from the market.

  • e able to drtlers ror damages. A new drug has been approved for use, and the...

    e able to drtlers ror damages. A new drug has been approved for use, and the drug manu- facturer has made it available for sale. During the first 6 months, the FDA receives reports of severe adverse effects that were not discovered during the testing and considers withdrawing the drug. This illustrates which phase of inves- tigational drug studies? a. Phase I b. Phase II c. Phase III d. Phase IV

  • QUESTION 2 Through the 1990's, clinical drug testing sites often only allowed Phase I testing in...

    QUESTION 2 Through the 1990's, clinical drug testing sites often only allowed Phase I testing in healthy males ages 18-45. Explain two therapeutic errors that could potentially result from such a policy,

  • Q1. FDA Form ________ is used for financial disclosure. A. 1571 B. 3412 C. 3430 D....

    Q1. FDA Form ________ is used for financial disclosure. A. 1571 B. 3412 C. 3430 D. 3455 QUESTION 2 Different from a traditional IND, expanded access programs do not require investigators to maintain compliance with the requirements of Part 312 subpart D. True Or False QUESTION 3 Which of the following are true statements? A. Expanded access use may begin 30 days after FDA's receipt of the request, NO exceptions B. For emergency access use the FDA must determine that...

  • nce of serious symptoms is longer for AIDS 27] A difference between AIDS and Ebola virus...

    nce of serious symptoms is longer for AIDS 27] A difference between AIDS and Ebola virus a) Only AIDS is acquired by exposure to bodily fluids b) Only Ebola is acquired by exposure to bodily fluids c) The time between infection and appearance of serious symptoms is onger d) The time between infection and a range of serious symptoms is loner for EDO 28) The first synthetie antibiotic was a) penicillin b) sulfonamide c) Salvarsan 606 d) Morphine 29) The...

  • In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug...

    In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug for treating a disease wants to investigate the effectiveness of this generic drug as compared to the traditional brand name drug, At the present time, the brand name drug is the only approved treatment for the disease. Patients diagnosed with the disease have low concentration of a specific factor in their blood. Treatment with the brand name drug will result in an increase in...

  • 3. in a phase I clinical trial for a new drug, one of the main goals...

    3. in a phase I clinical trial for a new drug, one of the main goals is to determine the recommended dose of the drug for phase II of the trial. Typically, the drug is tested with a low dose, and if deemed safe, the dose is escalated (increased) until toxicity becomes too high. A common pattern of dose escalation is to increase the dose by 67% after the first round, then 50% after the second round, 40% after the...

  • 12 ng which stage of the process of new drug 6. Duri testing on humans start?...

    12 ng which stage of the process of new drug 6. Duri testing on humans start? development does 4 A patient asked the nurse what would be an example 1. The preclinical research and development sta ge 2. The postmarketing surveillance stage 3. The postclinical research and development of an appropriate source for drug information on the internet. The nurse responds: 1. "The Internet is not an appropriate place to look up any drug information; you need to ask your...

  • A new weight-reducing technique, consisting of a liquid protein diet, is currently undergoing tests by the Food and Drug Administration (FDA) before its introduction into the market

    A new weight-reducing technique, consisting of a liquid protein diet, is currently undergoing tests by the Food and Drug Administration (FDA) before its introduction into the market. A typical test performed by the FDA is the following: The weights of a random sample of five people are recorded before they are introduced to the liquid protein diet. The five individuals are then instructed to follow the liquid protein diet for 3 weeks. At the end of this period, their weights...

ADVERTISEMENT
Free Homework Help App
Download From Google Play
Scan Your Homework
to Get Instant Free Answers
Need Online Homework Help?
Ask a Question
Get Answers For Free
Most questions answered within 3 hours.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT